Molecular Medicine |
From the Departments of Molecular and Cellular Physiology (J.D.), Surgery (J.D., M.M.), and Internal Medicine (T.N.), Graduate School of Medicine, University of Tokyo, Japan; Department of Physiology, Kanazawa University School of Medicine (Y.T.), Kanazawa, Japan; and Vascular Research Division, Department of Pathology, Brigham and Women's Hospital (T.C.), Boston, Mass.
Correspondence to Yoh Takuwa, MD, Department of Physiology, Kanazawa University School of Medicine, 13-1 Takara-machi, Kanazawa 920-8640, Japan. E-mail ytakuwa{at}med.kanazawa-u.ac.jp
AbstractPlatelet-derived growth factors (PDGFs) have been implicated in the pathogenesis of vascular proliferative disorders. Vascular smooth muscle cells (VSMCs) are one of the cell types that produce PDGF-B chain in proliferative lesions, although the mechanism of regulation of PDGF-B chain production in these cells is not well understood. In the present study, we demonstrate that angiotensin II (Ang II), which is also implicated in vascular stenosis after angioplasty and atherosclerosis, markedly stimulates PDGF-B chain mRNA expression in cultured newborn rat medial VSMCs and neointimal VSMCs via an AT1, but not in adult rat VSMCs. In newborn rat VSMCs, Ang II activates extracellular signalregulated protein kinase (ERK), c-Jun N-terminal protein kinase (JNK), and p38 mitogenactivated protein kinase. The mitogen-activated protein/ERK (MEK) inhibitor PD98059, but not the p38 inhibitor SB203580, abrogates Ang IIinduced PDGF-B mRNA expression. Transient transfection analysis using a PDGF-B promoter-luciferase gene reporter construct reveals that Ang II induces transcriptional activation of PDGF-B chain gene, which is abolished by the expression of a dominant negative form of either ERK or JNK, but not of p38. The expression of a dominant negative form of Ras abolishes the stimulatory effects of Ang II on ERK activity and PDGF-B mRNA expression. In adult rat VSMCs, Ang II activates ERK and JNK, but weakly induces Egr-1, a transcription factor implicated in PDGF-B chain gene expression, compared with newborn VSMCs. These data indicate that Ang II activates PDGF-B chain gene expression in VSMCs through mechanisms involving Ras-ERK and JNK.
Key Words: angiotensin II platelet-derived growth factor B chain vascular smooth muscle Ras mitogen-activated protein kinase
This article has been cited by other articles:
![]() |
N. Fukai, R. D. Kenagy, L. Chen, L. Gao, G. Daum, and A. W. Clowes Syndecan-1: An Inhibitor of Arterial Smooth Muscle Cell Growth and Intimal Hyperplasia Arterioscler Thromb Vasc Biol, September 1, 2009; 29(9): 1356 - 1362. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-i. Takashima, N. Sugimoto, N. Takuwa, Y. Okamoto, K. Yoshioka, M. Takamura, S. Takata, S. Kaneko, and Y. Takuwa G12/13 and Gq mediate S1P2-induced inhibition of Rac and migration in vascular smooth muscle in a manner dependent on Rho but not Rho kinase Cardiovasc Res, September 1, 2008; 79(4): 689 - 697. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Sanchez-Guerrero, V. C. Midgley, and L. M. Khachigian Angiotensin II induction of PDGF-C expression is mediated by AT1 receptor-dependent Egr-1 transactivation Nucleic Acids Res., April 1, 2008; 36(6): 1941 - 1951. [Abstract] [Full Text] [PDF] |
||||
![]() |
L.-J. Min, M. Mogi, J. Iwanami, J.-M. Li, A. Sakata, T. Fujita, K. Tsukuda, M. Iwai, and M. Horiuchi Cross-talk between aldosterone and angiotensin II in vascular smooth muscle cell senescence Cardiovasc Res, December 1, 2007; 76(3): 506 - 516. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Senokuchi, T. Matsumura, M. Sakai, M. Yano, T. Taguchi, T. Matsuo, K. Sonoda, D. Kukidome, K. Imoto, T. Nishikawa, et al. Statins Suppress Oxidized Low Density Lipoprotein-induced Macrophage Proliferation by Inactivation of the Small G Protein-p38 MAPK Pathway J. Biol. Chem., February 25, 2005; 280(8): 6627 - 6633. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Lassila, T. J. Allen, Z. Cao, V. Thallas, K. A. Jandeleit-Dahm, R. Candido, and M. E. Cooper Imatinib Attenuates Diabetes-Associated Atherosclerosis Arterioscler Thromb Vasc Biol, May 1, 2004; 24(5): 935 - 942. [Abstract] [Full Text] |
||||
![]() |
S. Usui, N. Sugimoto, N. Takuwa, S. Sakagami, S. Takata, S. Kaneko, and Y. Takuwa Blood Lipid Mediator Sphingosine 1-Phosphate Potently Stimulates Platelet-derived Growth Factor-A and -B Chain Expression through S1P1-Gi-Ras-MAPK-dependent Induction of Kruppel-like Factor 5 J. Biol. Chem., March 26, 2004; 279(13): 12300 - 12311. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Hashimoto, Y. Maeshima, M. Satoh, M. Odawara, H. Sugiyama, N. Kashihara, H. Matsubara, Y. Yamasaki, and H. Makino Overexpression of angiotensin type 2 receptor ameliorates glomerular injury in a mouse remnant kidney model Am J Physiol Renal Physiol, March 1, 2004; 286(3): F516 - F525. [Abstract] [Full Text] |
||||
![]() |
T. Minamino, T. Yoshida, K. Tateno, H. Miyauchi, Y. Zou, H. Toko, and I. Komuro Ras Induces Vascular Smooth Muscle Cell Senescence and Inflammation in Human Atherosclerosis Circulation, November 4, 2003; 108(18): 2264 - 2269. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Sugimoto, N. Takuwa, H. Okamoto, S. Sakurada, and Y. Takuwa Inhibitory and Stimulatory Regulation of Rac and Cell Motility by the G12/13-Rho and Gi Pathways Integrated Downstream of a Single G Protein-Coupled Sphingosine-1-Phosphate Receptor Isoform Mol. Cell. Biol., March 1, 2003; 23(5): 1534 - 1545. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. E. Brown and N. R. Kamal The Reed-Sternberg Cell: Molecular Characterization by Proteomic Analysis with Therapeutic Implications Ann. Clin. Lab. Sci., October 1, 2002; 32(4): 339 - 351. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Fiebeler, F. Schmidt, D. N. Muller, J.-K. Park, R. Dechend, M. Bieringer, E. Shagdarsuren, V. Breu, H. Haller, and F. C. Luft Mineralocorticoid Receptor Affects AP-1 and Nuclear Factor-{{kappa}}B Activation in Angiotensin II-Induced Cardiac Injury Hypertension, February 1, 2001; 37(2): 787 - 793. [Abstract] [Full Text] [PDF] |
||||
![]() |
P.-L. Tharaux, C. Chatziantoniou, F. Fakhouri, and J.-C. Dussaule Angiotensin II Activates Collagen I Gene Through a Mechanism Involving the MAP/ER Kinase Pathway Hypertension, September 1, 2000; 36(3): 330 - 336. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1999 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |